Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – Equities researchers at William Blair issued their Q1 2025 earnings per share estimates for shares of Axsome Therapeutics in a report released on Tuesday, May 9th. William Blair analyst M. Minter forecasts that the company will post earnings of ($0.34) per share for the quarter. The consensus […]
Axsome Therapeutics (NASDAQ:AXSM – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. AXSM has been the topic of a number of other reports. HC Wainwright reaffirmed a “buy” rating and issued a $200.00 price target on shares of […]
Axsome Therapeutics (NASDAQ:AXSM – Get Rating) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 8th. Analysts expect Axsome Therapeutics to post earnings of ($1.12) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link. Axsome […]